Kaiser Permanente Participating in AbbVie-Sponsored International Clinical Trial Targeting Ovarian Cancer with PARP Inhibitor Called Veliparib

Kaiser Permanente Participating in AbbVie-Sponsored International Clinical Trial Targeting Ovarian Cancer with PARP Inhibitor Called Veliparib

Kaiser Permanente Research radio recently interviewed Dr. Michael A Bookman, an oncologist and investigator with Kaiser, discussing his participation in an international clinical trial sponsored by AbbVie, focusing on a PARP inhibitor called Veliparib to treat ovarian...
UW-Madison Professor and Team To Lead The Nation’s Coordinating Center for the National Cancer Institute Cancer Prevention Clinical Trials Network

UW-Madison Professor and Team To Lead The Nation’s Coordinating Center for the National Cancer Institute Cancer Prevention Clinical Trials Network

KyungMann Kim, a professor of biostatistics and medical informatics at the UW School of Medicine and Public Health, has received a five-year, $11.8 million award from the NCI of the National Institutes of Health to set up and manage the Cancer Prevention Clinical...

Pin It on Pinterest